相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lung type II alveolar epithelial cells collaborate with CCR2+ inflammatory monocytes in host defense against poxvirus infection
Ning Yang et al.
NATURE COMMUNICATIONS (2022)
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
Zhuting Hu et al.
NATURE MEDICINE (2021)
Epicutaneous immunization with modified vaccinia Ankara viral vectors generates superior T cell immunity against a respiratory viral challenge
Youdong Pan et al.
NPJ VACCINES (2021)
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J. Chappell et al.
LANCET INFECTIOUS DISEASES (2021)
Vaccinia Virus: From Crude Smallpox Vaccines to Elaborate Viral Vector Vaccine Design
Onur Kaynarcalidan et al.
BIOMEDICINES (2021)
Emerging concepts in the science of vaccine adjuvants
Bali Pulendran et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells
Faezzah Baharom et al.
NATURE IMMUNOLOGY (2021)
Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity
Ji Wang et al.
SCIENCE (2020)
Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity
Sebastian Ols et al.
CELL REPORTS (2020)
Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway
Eui Ho Kim et al.
ELIFE (2020)
Efficient Induction of Cytotoxic T Cells by Viral Vector Vaccination Requires STING-Dependent DC Functions
Cornelia Barnowski et al.
FRONTIERS IN IMMUNOLOGY (2020)
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Gregory A. Poland et al.
LANCET (2020)
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Andrew G. Harrison et al.
TRENDS IN IMMUNOLOGY (2020)
Personal Neoantigen Cancer Vaccines: A Road Not Fully Paved
Edward F. Fritsch et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Lymph node conduits transport virions for rapid T cell activation
Glennys V. Reynoso et al.
NATURE IMMUNOLOGY (2019)
The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells
Julia Volckmar et al.
VACCINE (2019)
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox
Phillip R. Pittman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer
Heather L. Kinkead et al.
JCI INSIGHT (2018)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Migratory CD11b+ conventional dendritic cells induce T follicular helper cell-dependent antibody responses
Jayendra Kumar Krishnaswamy et al.
SCIENCE IMMUNOLOGY (2017)
Active dissemination of cellular antigens by DCs facilitates CD8+ T-cell priming in lymph nodes
Irina Gurevich et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells
Peihong Dai et al.
SCIENCE IMMUNOLOGY (2017)
Natural STING Agonist as an Ideal Adjuvant for Cutaneous Vaccination
Ji Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice
Zili Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: A randomised non-inferiority clinical trial
Javier Diez-Domingo et al.
VACCINE (2015)
Innate immune activation of NFκB and its antagonism by poxviruses
Gareth Brady et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
Modified Vaccinia Virus Ankara Triggers Type I IFN Production in Murine Conventional Dendritic Cells via a cGAS/STING-Mediated Cytosolic DNA-Sensing Pathway
Peihong Dai et al.
PLOS PATHOGENS (2014)
The origins and functions of dendritic cells and macrophages in the skin
Bernard Malissen et al.
NATURE REVIEWS IMMUNOLOGY (2014)
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
Miriam Merad et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination
Maria Vono et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects
Xiao-Dong Li et al.
SCIENCE (2013)
Clinical development of Modified Vaccinia virus Ankara vaccines
Sarah C. Gilbert
VACCINE (2013)
Exploiting the Mutanome for Tumor Vaccination
John C. Castle et al.
CANCER RESEARCH (2012)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
Innate Immune Response of Human Plasmacytoid Dendritic Cells to Poxvirus Infection Is Subverted by Vaccinia E3 via Its Z-DNA/RNA Binding Domain
Hua Cao et al.
PLOS ONE (2012)
The N-Ethyl-N-Nitrosourea-Induced Goldenticket Mouse Mutant Reveals an Essential Function of Sting in the In Vivo Interferon Response to Listeria monocytogenes and Cyclic Dinucleotides
John-Demian Sauer et al.
INFECTION AND IMMUNITY (2011)
Myxoma Virus Induces Type I Interferon Production in Murine Plasmacytoid Dendritic Cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-Dependent Pathway
Peihong Dai et al.
JOURNAL OF VIROLOGY (2011)
Programming the magnitude and persistence of antibody responses with innate immunity
Sudhir Pai Kasturi et al.
NATURE (2011)
Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months
Markus Knuf et al.
EUROPEAN JOURNAL OF PEDIATRICS (2010)
Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity
Luzheng Liu et al.
NATURE MEDICINE (2010)
Modified Vaccinia Virus Ankara Exerts Potent Immune Modulatory Activities in a Murine Model
Miriam Noerder et al.
PLOS ONE (2010)
Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing
Zhilong Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cutting Edge: Mucosal Application of a Lyophilized Viral Vector Vaccine Confers Systemic and Protective Immunity toward Intracellular Pathogens
Wolfgang Kastenmuller et al.
JOURNAL OF IMMUNOLOGY (2009)
Conventional Bone Marrow-Derived Dendritic Cells Contribute to Toll-Like Receptor-Independent Production of Alpha/Beta Interferon in Response to Inactivated Parapoxvirus Ovis
Sabine Siegemund et al.
JOURNAL OF VIROLOGY (2009)
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Troy D. Querec et al.
NATURE IMMUNOLOGY (2009)
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
Mirjam Kool et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity
Kai Hildner et al.
SCIENCE (2008)
Modified vaccinia virus Ankara induces toll-like receptor-independent type I interferon responses
Zoe Waibler et al.
JOURNAL OF VIROLOGY (2007)
Taking dendritic cells into medicine
Ralph M. Steinman et al.
NATURE (2007)
Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells
Liang Deng et al.
JOURNAL OF VIROLOGY (2006)
Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming
Rhys S. Allan et al.
IMMUNITY (2006)
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
H Bisht et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox
PL Earl et al.
NATURE (2004)
Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity
FR Carbone et al.
TRENDS IN IMMUNOLOGY (2004)
Vaccine adjuvants: Current state and future trends
N Petrovsky et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Duration of antiviral immunity after smallpox vaccination
E Hammarlund et al.
NATURE MEDICINE (2003)
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239
H Horton et al.
JOURNAL OF VIROLOGY (2002)
分享论文
